Enhancing the QUAlity and Transparency Of health Research
I recently gave a talk about guidelines to a group of postgraduate students at a well-known, well-resourced, and ancient university. The purpose of my talk was to explain the guidelines governing professional medical writers, as this was a careers day for biomedical researchers considering a move into the world of medical communications. To get some interaction, I started by asking the audience how many of them had already published their research in a peer-reviewed journal. All hands went up – these were mainly post-Docs, not people just embarking on a PhD. My next question was ‘Did you consult any reporting guidelines?’. This generated blank looks, so I rephrased it and asked ‘Have any of you heard of any reporting guidelines?’. One brave soul said something that was an only-slightly garbled version of CONSORT and somebody else had heard of ICMJE (not exactly reporting guidelines, but close enough). So I told them about CONSORT, and STROBE, and PRISMA, and the EQUATOR Network.
I then spoke about various guidelines that I didn’t expect them to know about, such as Good Publication Practice (mainly aimed at pharmaceutical companies – see GPP2) and guidelines for medical writers, such as those from the European Medical Writers Association. I explained that people working on publications (as writers or managers) generally took professionalism seriously and were expected to keep abreast of a wide range of guidelines. I told them about a recent survey I’d been involved with which suggested that such publications professionals were aware of these (and the reporting) guidelines and that drug companies and communication agencies took them seriously enough to audit compliance with them (see BMJ Open 4:e004780).
At the end of the talk, there were one or two questions about the role of medical writers, and on the tricky subject of authorship, but then an almost angry outburst from one participant who said ‘Why haven’t we been told about these guidelines before?’. I couldn’t answer that.
Liz Wager PhD is a freelance medical writer, editor, and trainer. She was the chair of the Committee on Publication Ethics (COPE) (2009-2012).
This Blog post has been reproduced with kind permission of the BMJ. The original blog post from the 12 June 2014 is available on the BMJ website at: http://blogs.bmj.com/bmj/2014/06/12/liz-wager-why-arent-researchers-told-about-reporting-guidelines/
How can reporting quality interfere with reproducibility issues and overall trust in science results? With that question in mind, we participated in the Reproducibility, Replicability and Trust in Science conference organised by the Wellcome Genome Campus from 9 to 11...